Liu, X., Zhao, Y., Zhang, L., Wang, J., Luo, L., Zhang, S., . . . Li, L. (2025). ANP32E expression in pancreatic cancer is associated with impaired gemcitabine efficacy and poor patient prognosis. Molecular and Cellular Probes, 82(102030-), . https://doi.org/10.1016/j.mcp.2025.102030
Chicago-referens (17:e uppl.)Liu, Xiaohong, et al. "ANP32E Expression in Pancreatic Cancer Is Associated with Impaired Gemcitabine Efficacy and Poor Patient Prognosis." Molecular and Cellular Probes 82, no. 102030- (2025). https://doi.org/10.1016/j.mcp.2025.102030.
MLA-referens (9:e uppl.)Liu, Xiaohong, et al. "ANP32E Expression in Pancreatic Cancer Is Associated with Impaired Gemcitabine Efficacy and Poor Patient Prognosis." Molecular and Cellular Probes, vol. 82, no. 102030-, 2025, https://doi.org/10.1016/j.mcp.2025.102030.
